SEK50.2 0.5 1.0%
Last Trade - 3:56pm
| Market Cap | £59.4m |
| Enterprise Value | £56.9m |
| Revenue | £1.18m |
| Position in Universe | 1034th / 1829 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.05 | 4.77 | 1.49 | 7.01 | 13.3 | 13.9 | 24.0 | 31.0 | +46.6% | ||
| +240 | ||||||||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
| Last Annual | December 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Public Since | June 17, 2015 |
| No. of Shareholders: | n/a |
| No. of Employees: | 5 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | AktieTorget Stock Exchange |
| Shares in Issue | 14,040,810 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | Gyllenhammarsvag 26, HALMSTAD, 302 92, Sweden |
| Web | http://www.redsensemedical.com/ |
| Phone | +46 35 106030 |
| Contact | () |
| Auditors | Baker Tilly International |
As of 3:56pm, shares in Redsense Medical AB (publ) are trading at SEK50.2, giving the company a market capitalisation of £59.4m. This share price information is delayed by 15 minutes.
Shares in Redsense Medical AB (publ) are currently trading at SEK50.2 and the price has moved by 0.285k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Redsense Medical AB (publ) price has moved by 0.188k% over the past year.
Of the analysts with advisory recommendations for Redsense Medical AB (publ), there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Redsense Medical AB (publ) is Not available. You can view the full broker recommendation list by unlocking its StockReport.
Redsense Medical AB (publ) is scheduled to issue upcoming financial results on the following dates:
Redsense Medical AB (publ) does not currently pay a dividend.
Redsense Medical AB (publ) does not currently pay a dividend.
Redsense Medical AB (publ) does not currently pay a dividend.
To buy shares in Redsense Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Redsense Medical AB (publ) are currently trading at SEK50.2, giving the company a market capitalisation of £59.4m.
Here are the trading details for Redsense Medical AB (publ):
Based on an overall assessment of its quality, value and momentum, Redsense Medical AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Redsense Medical AB (publ).
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redsense Medical AB (publ). Over the past six months, the relative strength of its shares against the market has been -11.12%. At the current price of SEK50.2, shares in Redsense Medical AB (publ) are trading at 11.58% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Redsense Medical AB (publ).
Redsense Medical AB (publ)'s management team is headed by:
Here are the top five shareholders of Redsense Medical AB (publ) based on the size of their shareholding:
